Phase I / II, multicenter, randomized and controlled clinical trial to assess the safety and efficacy of intravenous administration of expanded Allogeneic Adipose Tissue Adult Mesenchymal Stem cells in patients with severe pneumonia due to COVID-19
- Funded by Centro Regulador de Urgencias y Emergencias (CRUE Santander)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$169,500Funder
Centro Regulador de Urgencias y Emergencias (CRUE Santander)Principal Investigator
N/A
Research Location
SpainLead Research Institution
Universidad de SevillaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified